{"name":"Carolina Eyecare Physicians, LLC","slug":"carolina-eyecare-physicians-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Ilevro","genericName":"Ilevro","slug":"ilevro","indication":"Other","status":"marketed"},{"name":"Gatifloxacin Ophthalmic","genericName":"Gatifloxacin Ophthalmic","slug":"gatifloxacin-ophthalmic","indication":"Other","status":"marketed"},{"name":"TriMoxiVanc","genericName":"TriMoxiVanc","slug":"trimoxivanc","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"Pred-Gati-Brom","genericName":"Pred-Gati-Brom","slug":"pred-gati-brom","indication":"Post-operative inflammation and infection following ocular surgery","status":"marketed"},{"name":"Moxifloxacin HCl 0.5%","genericName":"Moxifloxacin HCl 0.5%","slug":"moxifloxacin-hcl-0-5","indication":"Bacterial conjunctivitis","status":"marketed"},{"name":"Prednisolone acetate 1% ophthalmic suspension","genericName":"Prednisolone acetate 1% ophthalmic suspension","slug":"prednisolone-acetate-1-ophthalmic-suspension","indication":"Inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Bromfenac 0.075% Oph Solution","genericName":"Bromfenac 0.075% Oph Solution","slug":"bromfenac-0-075-oph-solution","indication":"Postoperative inflammation and pain following ocular surgery","status":"marketed"}]}],"pipeline":[{"name":"Ilevro","genericName":"Ilevro","slug":"ilevro","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pred-Gati-Brom","genericName":"Pred-Gati-Brom","slug":"pred-gati-brom","phase":"marketed","mechanism":"Pred-Gati-Brom is a fixed-dose combination ophthalmic drop containing a corticosteroid, a GABA agonist, and a bromide salt that reduces intraocular pressure and inflammation in the eye.","indications":["Post-operative inflammation and infection following ocular surgery"],"catalyst":""},{"name":"Bromfenac 0.075% Oph Solution","genericName":"Bromfenac 0.075% Oph Solution","slug":"bromfenac-0-075-oph-solution","phase":"marketed","mechanism":"Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation in the eye.","indications":["Postoperative inflammation and pain following ocular surgery","Reduction of ocular inflammation and pain in patients undergoing cataract surgery"],"catalyst":""},{"name":"Gatifloxacin Ophthalmic","genericName":"Gatifloxacin Ophthalmic","slug":"gatifloxacin-ophthalmic","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Moxifloxacin HCl 0.5%","genericName":"Moxifloxacin HCl 0.5%","slug":"moxifloxacin-hcl-0-5","phase":"marketed","mechanism":"Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription in bacteria.","indications":["Bacterial conjunctivitis","Bacterial corneal ulcer","Other bacterial eye infections"],"catalyst":""},{"name":"Prednisolone acetate 1% ophthalmic suspension","genericName":"Prednisolone acetate 1% ophthalmic suspension","slug":"prednisolone-acetate-1-ophthalmic-suspension","phase":"marketed","mechanism":"Prednisolone acetate is a corticosteroid that suppresses inflammatory and immune responses in the eye by inhibiting phospholipase A2 and reducing production of inflammatory mediators.","indications":["Inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe","Steroid-responsive inflammatory conditions of the eye such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and selected infective conjunctivitides"],"catalyst":""},{"name":"TriMoxiVanc","genericName":"TriMoxiVanc","slug":"trimoxivanc","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":7,"phaseCounts":{"marketed":7},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}